Pacira BioSciences Overview
Pacira BioSciences Target Price
Analysts' 12-month price predictions for PCRX.
Share Price
$25.12
Average Target Price
$32.33
28.7% upside
28.7% upside3 analysts in the last 4 months
High: $48 | Low: $24
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-02-28 | Barclays | $24 |  4.5% downside |  |
| 2025-02-28 | H.C. Wainwright | $48 | 91.1% upside | |
| 2025-01-30 | Truist FinancialLes Sulewski | $25 | 0.5% downside | |
| 2024-11-07 | Piper SandlerDavid Amsellem | $12 | 52.2% downside | |
| 2024-09-24 | JefferiesGlen Santangelo | $18 | 28.3% downside | |
| 2024-08-13 | Truist FinancialLes Sulewski | $8 | 68.2% downside | |
| 2024-07-02 | H.C. WainwrightOren Livnat | $57 | 126.9% upside | |
| 2024-06-13 | JefferiesGlen Santangelo | $36 | 43.3% upside | |
| 2024-05-21 | Piper SandlerDavid Amsellem | $42 | 67.2% upside | |
| 2023-01-06 | BMO Capital | $52 | 107% upside | |
| 2023-01-06 | Needham | $63 | 150.8% upside | |